Fair Value of Financial Instruments (Tables)

6 Months Ended

Apr. 30, 2016

Fair Value Disclosures [Abstract]

Schedule of Fair Value of Financial Instruments

Fair Value Hierarchy of Our Financial Instruments

		Fair Value
(in millions)	Fair Value Hierarchy	April 30, 2016		October 31, 2015
Financial assets measured at fair value on a recurring basis
Assets held in funded deferred compensation plan(1)	1	$	4.8	$	5.3
Investments in auction rate securities(2)	3	8.0		13.0
Interest rate swap(3)	2	0.1		—
Other select financial assets
Cash and cash equivalents(4)	1	45.7		55.5
Insurance deposits(5)	1	11.4		11.4
Financial liabilities measured at fair value on a recurring basis
Interest rate swaps(3)	2	—		0.1
Contingent consideration liability(6)	3	5.2		5.2
Other select financial liability
Line of credit(7)	2	208.9		158.0

⁽¹⁾ Represents investments held in a Rabbi trust associated with one of our deferred compensation plans, which we include in “Other noncurrent assets” on the accompanying unaudited consolidated balance sheets. The fair value of the assets held in the funded deferred compensation plan is based on quoted market prices.

⁽²⁾ For investments in auction rate securities, the fair value was based on discounted cash flow valuation models, primarily utilizing unobservable inputs. These amounts are included in “Other investments” on the accompanying unaudited consolidated balance sheets. See Note 9, “Auction Rate Securities,” for further information.

⁽³⁾ Represents interest rate swap derivatives designated as cash flow hedges. The fair values of the interest rate swaps are estimated based on the present value of the difference between expected cash flows calculated at the contracted interest rates and the expected cash flows at current market interest rates using observable benchmarks for LIBOR forward rates at the end of the period. For 2016 the interest rate swap was included in “Other noncurrent assets,” and for 2015 the interest rate swaps were included in “Other accrued liabilities” on the accompanying unaudited consolidated balance sheets. See Note 11, “Line of Credit,” for more information.

⁽⁴⁾ Cash and cash equivalents are stated at nominal value, which equals fair value.

⁽⁵⁾ Represents restricted insurance deposits that are used to collateralize our insurance obligations and are stated at nominal value, which equals fair value. These insurance deposits are included in “Other noncurrent assets” on the accompanying unaudited consolidated balance sheets. See Note 10, “Insurance,” for further information.

⁽⁶⁾ Certain of our acquisitions involve the payment of contingent consideration. Depending on the structure of the contingent consideration arrangement, the fair value of the liability is based on either (i) the expected achievement of certain pre-established revenue goals or (ii) pre-defined forecasted adjusted income from operations using a probability weighted income approach. Our contingent consideration liabilities are included in “Other accrued liabilities” and “Other noncurrent liabilities” on the accompanying unaudited consolidated balance sheets.

⁽⁷⁾ Represents outstanding borrowings under our syndicated line of credit. Due to variable interest rates, the carrying value of outstanding borrowings under our line of credit approximates the fair value. See Note 11, “Line of Credit,” for further information.